Bvf I Gp LLC
Director, 10% owner at MLTX; Other at Merus N.V.
- Sold, on record
- $177M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Oct 4, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- MLTXMoonLake ImmunotherapeuticsDirector, 10% owner
- Merus N.V.Other
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- Merus N.V.3.3M shares
- MLTX2M shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Merus N.V.UnusualJul 2, 2021 2021
Sold 2.2M shares at $20.75 ($45.4M)
Bvf I Gp LLC, Other
Sold 87.5% of holdings ($51.8M position)311,210 shares leftFirst sale on recordFiling
- 2 Form 4 sale Merus N.V.UnusualOct 8, 2021 +98 days
Sold 1.1M shares at $27.56 ($31.2M)
Bvf I Gp LLC, Other
Sold 83% of holdings ($37.6M position)232,747 shares leftFiling
- 3 Form 4 sale MLTXUnusualOct 4, 2024 +1092 days
Sold 2M shares at $50.00 ($100M)
Bvf I Gp LLC, Director, 10% owner
No 10b5-1 planSold 60.8% of holdings ($164M position)1.3M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2024 | Oct 8, 2024 | MLTX | Director, 10% owner | Form 4 sale | 2M | $100M | 60.8% | Unusual | SEC |
| Oct 8, 2021 | Oct 8, 2021 | Merus N.V. | Other | Form 4 sale | 1.1M | $31.2M | 83.0% | Unusual | SEC |
| Jul 2, 2021 | Jul 7, 2021 | Merus N.V. | Other | Form 4 sale | 2.2M | $45.4M | 87.5% | Unusual | SEC |